Newsbenzinga
New Iza-bren Approvals Underscore China's Rising Role In Bispecific ADCs
· Published
Article summary
Iza-bren was approved for recurrent or metastatic esophageal squamous cell carcinoma, after receiving earlier approval to treat nasopharyngeal carcinoma image credit: Bamboo Works Key Takeaways: New
An excerpt from the original article.
Comments —
Loading comments…